3.Nuclear Medicine Theranostics: Perspective from Pakistan
Humayun BASHIR ; M Numair YOUNIS ; M Rehan GUL
Nuclear Medicine and Molecular Imaging 2019;53(1):38-41
Nuclear medicine has been offering diagnostic and therapeutic solution since the introduction of radioactive iodine for thyroid diseases since decades. However, the concept of theranostics has given a new found impetus to the use of pairs of radiopharmaceuticals for diagnosis and treatment. Presented here is a perspective on theranostics from Pakistan.
Diagnosis
;
Iodine
;
Nuclear Medicine
;
Pakistan
;
Radiopharmaceuticals
;
Theranostic Nanomedicine
;
Thyroid Diseases
4.Thyroid Hormone Resistance in a Preterm Infant with a Novel THRB Mutation
Joon Yeol BAE ; Dong Yeop KIM ; Young Dai KWON ; Young Hwa SONG ; Han Hyuk LIM ; Hyung Doo PARK ; Jae Woo LIM
Neonatal Medicine 2019;26(2):111-116
Resistance to thyroid hormone (RTH) is a condition caused by a mutation in the thyroid hormone receptor gene. It is rarely reported in individuals with no family history of RTH or in premature infants, and its clinical presentation varies. In our case, a premature infant with no family history of thyroid diseases had a thyroid stimulating hormone level of 85.0 µIU/mL and free thyroxine level of 1.64 ng/dL on a thyroid function test. The patient also presented with clinical signs of hypothyroidism, including difficulties in feeding and weight gain. The patient was treated with levothyroxine; however, only free thyroxine and triiodothyronine levels increased without a decrease in thyroid-stimulating hormone levels. Taken together with thyroid gland hypertrophy observed on a previous ultrasound examination, RTH was suspected and the diagnosis was eventually made based on a genetic test. A de novo mutation in the thyroid hormone receptor β gene in the infant was found that has not been previously reported. Other symptoms included tachycardia and pulmonary hypertension, but gradual improvement in the symptoms was observed after liothyronine administration. This report describes a case involving a premature infant with RTH and a de novo mutation, with no family history of thyroid disease.
Diagnosis
;
Goiter
;
Humans
;
Hypertension, Pulmonary
;
Hypertrophy
;
Hypothyroidism
;
Infant
;
Infant, Newborn
;
Infant, Premature
;
Receptors, Thyroid Hormone
;
Tachycardia
;
Thyroid Diseases
;
Thyroid Function Tests
;
Thyroid Gland
;
Thyroid Hormone Receptors beta
;
Thyroid Hormone Resistance Syndrome
;
Thyrotropin
;
Thyroxine
;
Triiodothyronine
;
Ultrasonography
;
Weight Gain
5.Psychotic Symptoms of Hashimoto's Encephalopathy: A Diagnostic Challenge
Monisha K SAVARIMUTHU ; Sherab TSHERINGLA ; Priya MAMMEN
Journal of the Korean Academy of Child and Adolescent Psychiatry 2019;30(1):42-44
Hashimoto's encephalopathy (HE) is a rare and underdiagnosed neuropsychiatric illness. We present the case of a 17-year-old girl who was admitted to a tertiary-care psychiatric center with acute onset psychosis and fever. Her psychotic symptoms were characterized by persecutory and referential delusions, as well as tactile and visual hallucinations. Her acute behavioral disturbance warranted admission and treatment in a psychiatric setting (risperidone tablets, 3 mg/day). She had experienced an episode of fever with a unilateral visual acuity defect approximately 3 years before admission, which was resolved with treatment. Focused clinical examination revealed an enlarged thyroid, and baseline blood investigations, including thyroid function test results were normal. Abnormal laboratory investigations revealed elevated anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-TG) levels (anti-TPO of 480 IU/mL; anti-TG of 287 IU/mL). Results of other investigations for infection, including cerebrospinal fluid examination, electroencephalography, and brain magnetic resonance imaging were normal. She was diagnosed with HE and was treated with intravenous corticosteroids (methylprednisolone up to 1 g/day; tapered and discontinued after a month). The patient achieved complete remission of psychotic symptoms and normalization of the anti-thyroid antibody titers. Currently, at the seventh month of follow-up, the patient is doing well. This case highlights the fact that in the absence of well-defined clinical diagnostic criteria, a high index of suspicion is required for early diagnosis of HE. Psychiatrists need to explore for organic etiologies when dealing with acute psychiatric symptoms in a younger age group.
Adolescent
;
Adrenal Cortex Hormones
;
Brain
;
Brain Diseases
;
Cerebrospinal Fluid
;
Delusions
;
Early Diagnosis
;
Electroencephalography
;
Female
;
Fever
;
Follow-Up Studies
;
Hallucinations
;
Humans
;
Magnetic Resonance Imaging
;
Methylprednisolone
;
Peroxidase
;
Psychiatry
;
Psychotic Disorders
;
Risperidone
;
Tablets
;
Thyroid Function Tests
;
Thyroid Gland
;
Visual Acuity
6.Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy
Eun Heui KIM ; Yun Kyung JEON ; Kyoungjune PAK ; In Joo KIM ; Seong Jang KIM ; Seunghyeon SHIN ; Bo Hyun KIM ; Sang Soo KIM ; Byung Joo LEE ; Jeong Gyu LEE ; Tae Sik GOH ; Keunyoung KIM
Journal of Bone Metabolism 2019;26(1):31-38
BACKGROUND: This study examined the change in the trabecular bone score (TBS), areal bone mineral density (aBMD), and osteoporosis in postmenopausal women who underwent thyrotropin (TSH)-suppressive therapy for treating papillary thyroid cancer after a total thyroidectomy procedure. METHODS: We evaluated 36 postmenopausal women who received a total thyroidectomy for papillary thyroid cancer and were undergoing TSH suppressive therapy with levothyroxine. Postmenopausal women (n=94) matched for age and body mass index were recruited as healthy controls. The aBMD and TBS of the lumbar spine were compared between dual energy X-ray absorptiometry (DXA) at baseline and at follow-up after an average of 4.92 years. RESULTS: There was no significant difference in the rate of diagnoses of osteoporosis, osteopenia, or normal bone status between the 2 groups during the baseline DXA evaluation. However, the TBS was significantly lower whereas aBMD did not show significant difference at the time of baseline DXA measurement (1st DXA, 1.343±0.098 vs. 1.372±0.06317, P < 0.001; 2nd DXA, 1.342±0.095 vs. 1.370±0.062, P < 0.001). The TBS and aBMD did not differ significantly between the initial and follow-up DXA images in both groups of TSH suppressive patients and controls. CONCLUSIONS: The average value of TBS and aBMD did not significantly change during the follow-up period. The TSH suppressive therapy was revealed as not a significant factor for the progressive deterioration of bone status during long term follow-up.
Absorptiometry, Photon
;
Body Mass Index
;
Bone Density
;
Bone Diseases, Metabolic
;
Diagnosis
;
Female
;
Follow-Up Studies
;
Humans
;
Osteoporosis
;
Postmenopause
;
Spine
;
Thyroid Neoplasms
;
Thyroidectomy
;
Thyrotropin
;
Thyroxine
7.Digital Medicine in Thyroidology: A New Era of Managing Thyroid Disease
Jae Hoon MOON ; Steven R STEINHUBL
Endocrinology and Metabolism 2019;34(2):124-131
Digital medicine has the capacity to affect all aspects of medicine, including disease prediction, prevention, diagnosis, treatment, and post-treatment management. In the field of thyroidology, researchers are also investigating potential applications of digital technology for the thyroid disease. Recent studies using artificial intelligence (AI)/machine learning (ML) have reported reasonable performance for the classification of thyroid nodules based on ultrasonographic (US) images. AI/ML-based methods have also shown good diagnostic accuracy for distinguishing between benign and malignant thyroid lesions based on cytopathologic findings. Assistance from AI/ML methods could overcome the limitations of conventional thyroid US and fine-needle aspiration cytology. A web-based database has been developed for thyroid cancer care. In addition to its role as a nationwide registry of thyroid cancer, it is expected to serve as a clinical platform to facilitate better thyroid cancer care and as a research platform providing comprehensive disease-specific big data. Evidence has been found that biosignal monitoring with wearable devices may predict thyroid dysfunction. This real-world thyroid function monitoring could aid in the management and early detection of thyroid dysfunction. In the thyroidology field, research involving the range of digital medicine technologies and their clinical applications is expected to be even more active in the future.
Artificial Intelligence
;
Biopsy, Fine-Needle
;
Classification
;
Diagnosis
;
Hyperthyroidism
;
Hypothyroidism
;
Learning
;
Machine Learning
;
Thyroid Diseases
;
Thyroid Gland
;
Thyroid Neoplasms
;
Thyroid Nodule
8.Prevalence of autoimmune thyroiditis in patients with type 1 diabetes: a long-term follow-up study.
Gum Bit HWANG ; Jong Seo YOON ; Kyu Jung PARK ; Hae Sang LEE ; Jin Soon HWANG
Annals of Pediatric Endocrinology & Metabolism 2018;23(1):33-37
PURPOSE: Type 1 diabetes mellitus (DM) is associated with autoimmune diseases such as thyroiditis. Therefore, we aimed to investigate the prevalence of autoimmune thyroiditis in patients with type 1 DM. METHODS: A total of 102 patients who were diagnosed and followed up (mean age, 8.1±4.0 years) in Ajou University Hospital were enrolled in this study. All the patients were evaluated for beta cell autoimmunity, including insulin autoantibody, glutamic acid decarboxylase antibodies (GADA), and islet cell antibody. Moreover, autoantibodies to thyroid peroxidase and thyroglobulin were assessed at initial diagnosis and annually thereafter. RESULTS: The mean patient age (49 men and 53 women) was 19.2±4.8 years. The prevalence of at least one thyroid antibody was 30.4%. Patients with thyroid antibodies had a significantly higher frequency of GADA at the time of the diagnosis. Autoimmune thyroiditis was more prevalent in the older age group. GADA was a significant risk factor for development of thyroid autoantibodies after diagnosis of type 1 DM (odds ratio, 4.45; 95% confidence interval, 1.399–14.153). CONCLUSIONS: In patients with type 1 DM, the prevalence of autoimmune thyroiditis was higher than in the general population. Moreover, GADA positivity at diagnosis was associated with thyroid autoimmunity.
Antibodies
;
Autoantibodies
;
Autoimmune Diseases
;
Autoimmunity
;
Diabetes Mellitus, Type 1
;
Diagnosis
;
Follow-Up Studies*
;
Glutamate Decarboxylase
;
Humans
;
Insulin
;
Iodide Peroxidase
;
Islets of Langerhans
;
Male
;
Prevalence*
;
Risk Factors
;
Thyroglobulin
;
Thyroid Gland
;
Thyroiditis
;
Thyroiditis, Autoimmune*
9.Atrial fibrillation without cardiac anomaly in a 9-year-old child
Myung Hoon BANG ; Sung Hye KIM
Pediatric Emergency Medicine Journal 2018;5(2):67-71
Atrial fibrillation (AF), the most common chronic arrhythmia in adults, is rarely reported in children. Moreover, most of the previously reported children with AF have comorbidities, such as structural heart diseases, rheumatic diseases, and thyroid diseases. This case report is about a healthy 9-year-old boy who was diagnosed with AF without cardiac anomaly. He visited the emergency department with chest pain and palpitation, lasting 2 hours. His electrocardiogram showed narrow-complex tachycardia, which led to the diagnosis of supraventricular tachycardia. The administration of adenosine revealed rapid irregular P waves. After electrical cardioversion, cardiac rhythm was converted to normal sinus rhythm. This case report suggests that when children with narrow-complex tachycardia visit the emergency department, the possibility of AF, in addition to supraventricular tachycardia, should be considered if the RR intervals are markedly irregular.
Adenosine
;
Adult
;
Arrhythmias, Cardiac
;
Atrial Fibrillation
;
Cardiovascular Diseases
;
Chest Pain
;
Child
;
Comorbidity
;
Diagnosis
;
Electric Countershock
;
Electrocardiography
;
Emergency Service, Hospital
;
Humans
;
Male
;
Pediatrics
;
Rheumatic Heart Disease
;
Tachycardia
;
Tachycardia, Supraventricular
;
Thyroid Diseases
10.Interpretation of puzzling thyroid function tests
Journal of the Korean Medical Association 2018;61(4):241-247
With the generalized use of highly sensitive thyroid stimulating hormone (TSH) and free thyroid hormone assays, most thyroid function tests (TFTs) are straightforward to interpret and confirm the clinical impressions of thyroid diseases. However, in some patients, TFT results can be perplexing because the clinical picture is not compatible with the tests or because TSH and free T4 are discordant with each other. Optimizing the interpretation of TFTs requires a complete knowledge of thyroid hormone homeostasis, an understanding of the range of tests available to the clinician, and the ability to interpret biochemical abnormalities in the context of the patient's clinical thyroid status. The common etiologic factors causing puzzling TFT results include intercurrent illness (sick euthyroid syndrome), drugs, alteration in normal physiology (pregnancy), hypothalamic-pituitary diseases, rare genetic disorders, and assay interference. Sick euthyroid syndrome is the most common cause of TFT abnormalities encountered in the hospital. In hypothalamic-pituitary diseases, TSH levels are unreliable. Therefore, it is not uncommon to see marginally high TSH levels in central hypothyroidism. Drugs may be the culprit of TFT abnormalities through various mechanisms. Patients with inappropriate TSH levels need a differential diagnosis between TSH-secreting pituitary adenoma and resistance to thyroid hormone. Sellar magnetic resonance imaging, serum α-subunit levels, serum sex hormone-binding globulin levels, a thyrotropin-releasing hormone stimulation test, trial of somatostatin analogues, and TR-β sequencing are helpful for the diagnosis, but it may be challenging. TFTs should be interpreted based on the clinical context of the patient, not just the numbers and reference ranges of the tests, to avoid various pitfalls of TFTs and unnecessary costly evaluations and therapies.
Diagnosis
;
Diagnosis, Differential
;
Diagnostic Errors
;
Euthyroid Sick Syndromes
;
Homeostasis
;
Humans
;
Hyperthyroidism
;
Hypothyroidism
;
Magnetic Resonance Imaging
;
Physiology
;
Pituitary Neoplasms
;
Rare Diseases
;
Reference Values
;
Sex Hormone-Binding Globulin
;
Somatostatin
;
Thyroid Diseases
;
Thyroid Function Tests
;
Thyroid Gland
;
Thyrotropin
;
Thyrotropin-Releasing Hormone

Result Analysis
Print
Save
E-mail